Cancer cell stemness, responses to experimental genotoxic treatments, cytomegalovirus protein expression and DNA replication stress in pediatric medulloblastomas

Cell Cycle. 2020 Apr;19(7):727-741. doi: 10.1080/15384101.2020.1728025. Epub 2020 Feb 13.

Abstract

Despite recent progress in research on brain tumors, including identification of cancer stem-like cells (CSCs), little is known about the interplay of stemness with the commonly observed infection by the human cytomegalovirus (HCMV) and the widespread features of replication stress in these malignancies. To shed more light on these outstanding issues, here we combine immunohistochemical analysis of archival clinical specimens from a cohort of 25 human pediatric medulloblastomas, complemented by functional experiments and analytical approaches to examine three medulloblastoma cell lines. In the clinical samples, we find consistent, yet individually variable subsets of CSCs expressing the stem-cell markers CD133 and CD15, and a candidate marker VEGFR2, across the spectrum of endogenous DNA damage (γH2AX), expression of HCMV immediate early and late proteins, proliferation rate (Ki67) or molecular class of MB. Contrary to MB cell lines DAOY and D324, the D283 cells showed pronounced phenotypic features of stemness, associated with enhanced endogenous DNA damage, exceptionally high susceptibility to infection with HCMV, unorthodox signaling pathway response to ionizing radiation and hyperactive response to hydroxyurea-induced replication stress. Notably, single-molecule DNA fiber analysis revealed aberrantly slow replication fork progression, pronounced fork asymmetry and inability to timely recover from drug-induced fork stalling in stem-like D283 cells, all hallmarks of pronounced chronic replication stress and propensity to genomic instability. These findings provide insights into human medulloblastoma stemness phenotypes, with various susceptibilities to infection by HCMV and impact on replication fork (mal)function, with implications for better understanding pathogenesis and responses to treatment in pediatric brain malignancies.Abbreviations: CSC: cancer stem-like cells; FBS: fetal bovine serum; HCMV: human cytomegalovirus; MB: medulloblastoma; MBSC: medulloblastoma stem cells; MOI: multiplicity of infection; PBS: phosphate-buffered saline; RPA: replication protein A; RS: replication stress; SHH: sonic hedgehog; VEGFR2: vascular endothelia growth factor receptor 2.

Keywords: Cancer stem cells; DNA damage; human cytomegalovirus; medulloblastoma; replication stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / metabolism
  • Cell Line, Tumor
  • Cerebellar Neoplasms / metabolism
  • Cerebellar Neoplasms / pathology*
  • Child
  • Cytomegalovirus / metabolism*
  • Cytomegalovirus / pathogenicity
  • DNA Replication*
  • Humans
  • Medulloblastoma / metabolism
  • Medulloblastoma / pathology*
  • Mutagens / toxicity*
  • Neoplastic Stem Cells / pathology*
  • Radiation, Ionizing
  • Signal Transduction
  • Viral Proteins / metabolism*

Substances

  • Biomarkers, Tumor
  • Mutagens
  • Viral Proteins

Grants and funding

This work was supported by the Lundbeck Foundation (R266-2017-4289), the Danish Cancer Society (R204-A12617), the Danish Council for Independent Research (DFF-7016-00313), the Swedish Research Council (VR-MH 2014-46602-117891-30 and K2013—57X-12615-16-5), the Swedish CancerFonden (150872, 170176), the Novo Nordisk Foundation and the Danish National Research Foundation (DNRF125: project CARD).